Nutex Health (NASDAQ:NUTX) released its Q4 earnings on Thursday, March 5, 2026 at 04:45 PM.Here's what's important from the earnings announcement.EarningsNutex Health missed estimated earnings by -71.04%, reporting an EPS of $1.61 versus an estimate of $5.56.Revenue was down $105.94 million from the same period last year.Performance in Previous EarningsLast quarter the company beat on EPS ...Full story available on Benzinga.com
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) CAO Theodore Alan Huizenga sold 1,632 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $22.80, for a total value of $37,209.60. Following the sale,
CrowdStrike (NASDAQ:CRWD – Free Report) – Stock analysts at Scotiabank increased their FY2027 earnings per share estimates for CrowdStrike in a research report issued to clients and investors on Thursday, March 5th. Scotiabank analyst P. Colville now expects that the company will post earnings per share of $0.87 for the
Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD – Get Free Report) Director Anthony Kuczinski bought 1,000 shares of Skyward Specialty Insurance Group stock in a transaction dated Tuesday, March 3rd. The shares were acquired at an average cost of $48.13 per share, with a total value of $48,130.
WiseTech Global Limited (ASX:WTC – Get Free Report) insider Andrew Harrison purchased 1,000 shares of WiseTech Global stock in a transaction dated Friday, February 27th. The stock was acquired at an average price of A$48.20 per share, with a total value of A$48,200.00. WiseTech
